XML 46 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration, License and Success Payment Agreements - Summary of Changes in Deferred Revenue (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
GSK License Contract [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Deferred revenue balance at September 30, 2021 $ 0
GSK Research and Development Services Contract [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Deferred revenue balance at December 31, 2020 95,161
Revenue recognized during the period previously recorded in deferred revenue (7,697)
Deferred revenue balance at September 30, 2021 $ 87,464